Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-25-000376
Filing Date
2025-08-14
Accepted
2025-08-14 12:12:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5922
  Complete submission text file 0001897612-25-000376.txt   7853
Mailing Address RADNOR CORPORATE CENTER, BUILDING ONE SUITE 200, 100 MATSONFORD ROAD RADNOR PA 19087
Business Address RADNOR CORPORATE CENTER, BUILDING ONE SUITE 200, 100 MATSONFORD ROAD RADNOR PA 19087 (610) 386-1700
Avantor, Inc. (Subject) CIK: 0001722482 (see all company filings)

EIN.: 822758923 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91022 | Film No.: 251216290
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1307 POINT STREET BALTIMORE MD 21231
Business Address 1307 POINT STREET BALTIMORE MD 21231 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A